Choksi Laboratories Intrinsic Value
CHOKSILA Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹32.40 | ₹25.92 - ₹38.88 | -66.6% | EPS: ₹2.70, Sector P/E: 12x |
| Book Value Method | asset | ₹34.29 | ₹30.86 - ₹37.72 | -64.7% | Book Value/Share: ₹34.29, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹52.57 | ₹47.31 - ₹57.83 | -45.8% | Revenue/Share: ₹65.71, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹111.43 | ₹100.29 - ₹122.57 | +14.8% | EBITDA: ₹13.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹232.86 | ₹186.29 - ₹279.43 | +139.9% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹43.20 | ₹38.88 - ₹47.52 | -55.5% | EPS Growth: 20.0%, Fair P/E: 16.0x |
| Growth Adjusted P/E | growth | ₹29.11 | ₹26.20 - ₹32.02 | -70.0% | Revenue Growth: 11.3%, Adj P/E: 8.5x |
| ROE Based Valuation | profitability | ₹48.52 | ₹43.67 - ₹53.37 | -50.0% | ROE: 8.3%, P/E Multiple: 10x |
| Graham Defensive Method | conservative | ₹45.64 | ₹41.08 - ₹50.20 | -53.0% | EPS: ₹2.70, BVPS: ₹34.29 |
Want to compare with current market value? Check CHOKSILA share price latest .
Valuation Comparison Chart
CHOKSILA Intrinsic Value Analysis
What is the intrinsic value of CHOKSILA?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Choksi Laboratories (CHOKSILA) is ₹45.64 (median value). With the current market price of ₹97.05, this represents a -53.0% variance from our estimated fair value.
The valuation range spans from ₹29.11 to ₹232.86, indicating ₹29.11 - ₹232.86.
Is CHOKSILA undervalued or overvalued?
Based on our multi-method analysis, Choksi Laboratories (CHOKSILA) appears to be trading above calculated value by approximately 53.0%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 0.89 | Industry Standard: 2.0+ | Below 1.5 | Measures short-term liquidity capacity |
| Return on Equity | 8.3% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 27.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.71x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
Related Pages for Choksi Laboratories
Additional stock information and data for CHOKSILA
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹12 Cr | ₹8 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹12 Cr | ₹9 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹8 Cr | ₹8 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹8 Cr | ₹7 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹6 Cr | ₹2 Cr | Positive Free Cash Flow | 7/10 |